Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Gastric Cancer

Free Subscription Articles published in Lancet Retrieve available abstracts of 9 articles: HTML format Text format

Single Articles

January 2012
1. NISHIDA T
   Adjuvant therapy for gastric cancer after D2 gastrectomy.
   Lancet. 2012.
   PubMed     Text format     Related articles   
   
   
   
   
2. BANG YJ , Kim YW, Yang HK, Chung HC, et al
   Adjuvant capecitabine and oxaliplatin for gastric cancer after D2 gastrectomy (CLASSIC): a phase 3 open-label, randomised controlled trial.
   Lancet. 2012.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
3. SASAKI S
   The value of the National Health and Nutrition Survey in Japan.
   Lancet. 2011.
   PubMed     Text format     Related articles   
   
   
   
   July 2011
4. MAZZOLENI LE , Francesconi CF, Sander GB
   Mass eradication of Helicobacter pylori: feasible and advisable?
   Lancet. 2011.
   PubMed     Text format     Related articles   
   
   
   
   November 2010
5. MUNRO AJ , Niblock PG
   Trastuzumab for gastric cancer treatment - Authors' reply.
   Lancet. 2010;376:1736-7.
   PubMed     Text format     Related articles   
   
   
   
   
6. OKINES AF , Dewdney A, Chau I, Rao S, et al
   Trastuzumab for gastric cancer treatment.
   Lancet. 2010;376:1736.
   PubMed     Text format     Related articles   
   
   
   
   
7. BANG YJ , Van Cutsem E, Lehle M, Hill J, et al
   Trastuzumab for gastric cancer treatment - Authors' reply.
   Lancet. 2010;376:1735-6.
   PubMed     Text format     Related articles   
   
   
   
   
8. FUJITA T
   Trastuzumab for gastric cancer treatment.
   Lancet. 2010;376:1735.
   PubMed     Text format     Related articles   
   
   
   
   August 2010
9. BANG YJ , Van Cutsem E, Feyereislova A, Chung HC, et al
   Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial.
   Lancet. 2010;376:687-97.
   PubMed     Text format     Related articles    Abstract available
   
   
   

Thank you for your interest in scientific medicine.

Amedeo is a Flying Publisher website.    Design: